CRISPR is at it again: this time providing a single-dose option to cure a debilitating genetic disorder called hereditary angioedema. Patients who took part in the first human trial have reported dramatic improvements in their health and quality of life, easing or completely removing the painful and potentially fatal swelling that arises from the condition. […]

The post Single-Dose of Gene Therapy Hailed as ‘Magic Wand’ for Patients with Deadly Condition, Transforming Lives appeared first on Good News Network.



from Good News Network https://ift.tt/SnpKM8x